EUVIMEDEUVIMED entdecken
Crossref

Loss of MTA2 ‐mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK‐MMP7 axis

Huang-Ming Hu, Hsiang-Lin Lee, Chung-Jung Liu iD, Yi-Hsien Hsieh iD, Yong-Syuan Chen, Kuan-Chun Hsueh

Environmental Toxicology · 2024-04 · 39 (4) · 1897-1908

DOI: 10.1002/tox.24073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 05.12.2023. Verfasst von Huang-Ming Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Repressor Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital Taichung, Taiwan, Kaohsiung Medical University Hospital, Kaohsiung Medical University Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression of metastasis tumor‐associated protein 2 (MTA2) and protein tyrosine kinase 7 (PTK7) is associated with hepatocellular carcinoma (HCC) progression. However, the functional effect and mechanism through which MTA2 regulates PTK7‐mediated HCC progression remains unclear. Here, we found that MTA2 knockdown significantly down‐regulated PTK7 expression in HCC cells (SK‐Hep‐1 and PLC/PRF/5). Data from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases show that the PTK7 expression level was higher in HCC tissues than in normal liver tissues. In HCC patients, the PTK7 expression level clearly correlated with tumor stage and grade, lower overall survival (OS) correlated positively with MTA2 level, and PTK7 expression acted as a downstream factor for MTA2 expression. In addition, matrix metalloproteinase 7 (MMP7) expression was closely regulated by PTK7, and the mRNA and protein expression levels of MTA2 and PTK7 correlated positively with lower OS. MMP7 downregulation by PTK7 knockdown clearly decreased the migration and invasion abilities of HCC cells. In HCC cells, recombinant human MMP7 reversed the PTK7 knockdown‐induced suppression of migration and invasion. Furthermore, deactivation of FAK using siFAK or FAK inhibitor (PF‐573228, PF) synergistically contributed to PTK7 knockdown‐inhibited FAK activity, MMP7 expression, and the migration and invasion abilities of HCC cells. Collectively, our findings show that PTK7 mediates HCC progression by regulating the MTA2‐FAK‐MMP7 axis and may be a diagnostic value for HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRepressor ProteinsHumansMatrix Metalloproteinase 7Down-RegulationCell MovementNeoplasm ProteinsCell Line, TumorGene Expression Regulation, NeoplasticNeoplasm InvasivenessCell Adhesion MoleculesReceptor Protein-Tyrosine KinasesHistone Deacetylases

Stichwörter der Autor:innen

hepatocellular carcinomainvasionmatrix metalloproteinase 7metastasis tumor-associated protein-2migrationprotein tyrosine kinase 7

Substanzen

Matrix Metalloproteinase 7Neoplasm ProteinsPTK7 protein, humanCell Adhesion MoleculesReceptor Protein-Tyrosine KinasesMMP7 protein, humanMTA2 protein, humanHistone DeacetylasesRepressor Proteins

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan.
  • Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Deptartment of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Chung-Jung Liu, Yi-Hsien Hsieh

Förderung

  • Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital Taichung, Taiwan
  • Kaohsiung Medical University Hospital
  • Kaohsiung Medical University Research Center
  • Kaohsiung Municipal Ta-Tung Hospital
  • KMTTH

Zitieren

APA

Hu, H. M., Lee, H. L., Liu, C. J., Hsieh, Y. H., Chen, Y. S., & Hsueh, K. C. (2024). Loss of MTA2 ‐mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK‐MMP7 axis. Environmental Toxicology, 39(4), 1897-1908. https://doi.org/10.1002/tox.24073

Vancouver

Hu HM, Lee HL, Liu CJ, Hsieh YH, Chen YS, Hsueh KC. Loss of MTA2 ‐mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK‐MMP7 axis. Environmental Toxicology. 2024;39(4):1897-1908. doi:10.1002/tox.24073

BibTeX
@article{Hu2024,
  author = {Hu, Huang-Ming and Lee, Hsiang-Lin and Liu, Chung-Jung and Hsieh, Yi-Hsien and Chen, Yong-Syuan and Hsueh, Kuan-Chun},
  title = {Loss of MTA2 ‐mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK‐MMP7 axis},
  journal = {Environmental Toxicology},
  year = {2024},
  volume = {39},
  number = {4},
  pages = {1897--1908},
  doi = {10.1002/tox.24073}
}
Kostenlos starten →